Speech Intelligibility in Noise Using the Hearing in Noise Test (HINT)
NCT ID: NCT01309503
Last Updated: 2011-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2011-03-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Language Proficiency and Quality of Life After Receiving Cochlear Implantation as a Child
NCT01863875
Evaluation of the Global Auditory Nerve Activity for Exploration of Hearing in Humans
NCT03552224
Speech Perception for Children With Cochlear Implants
NCT01059838
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
NCT07192757
Hearing Impairment, Cognitive Therapy and Coping
NCT01206829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal hearing
Children and adults
No interventions assigned to this group
Unilateral hearing loss
No interventions assigned to this group
Severe hearing loss high frequencies
No interventions assigned to this group
Adult CI users
Unilateral and bilateral CI
No interventions assigned to this group
Bilateral CI users
Children and adults
Sequential CIs
Simultaneous CIs
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
* Adults between age 18 and 50 years
* Children at different age groups between 6 and 12 years old
2. Unilateral hearing loss group
* Single-sided hearing loss.
* Using hearing aid or willing to try hearing aid on the side with hearing loss to estimate a potential binaural benefit with hearing aid.
* Contralateral normal hearing with audiometric thresholds less than or equal to 25 dB HL for octave frequencies between 250 Hz and 8000 Hz
3. Group with Severe hearing loss at high frequencies
4. Adult CI users with unilateral and bilateral CI
* All adult patients will be tested to the level of their performance.
* HINT SRTs will be collected if HINT score in quiet is above 70%.
5. Bilateral CI users (Children)
1. Sequential CIs group
* Children that has got two CIs in two different operations, and operations are not within one year.
* Inclusion of some of the patients participating in another ongoing sequential CI-study at the ENT department,and who has a HINT score above 70% in quiet. The requirement of a quiet percentage score above 70% is due to the bilateral benefit testing/estimation.
2. Simultaneous CIs group
* All children that has got two CIs in the same operation or sequentially within one year.
* Children older than 6 years old.
* Children as young as 5.5 years old can be included if they are considered ready for extended HINT testing.
Exclusion Criteria
5 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Oslo University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marte Myhrum, M.Sc.
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Greg Jablonski, PhD
Role: STUDY_CHAIR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo university hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010/743a (REK )
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.